Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05291533 · ClinicalTrials.gov registry record · NA

Patient Experiences With Virtual Reality Mindfulness Skills Training

A NA study of Anxiety and Distress, Emotional, sponsored by Weill Medical College of Cornell University.

Completed
Registry status
NA
Development phase
29
Enrollment target
1
Study location

NCT05291533 is a NA study of Anxiety and Distress, Emotional that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 29 participants, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05291533, a NA study of Anxiety and Distress, Emotional, has completed, sponsored by Weill Medical College of Cornell University.

COMPLETED
Registry status
NA
Development phase
29 participants
Enrollment target
1
Study location

Study Summary

This study aims to assess acceptability and preliminary efficacy of an intervention being administered clinically, a virtual reality (VR) mindfulness program. It is hypothesized that patients will find VR mindfulness an acceptable intervention and that it will reduce symptoms of anxiety.

Interventions

  • OTHER Virtual Reality (VR) Mindfulness Program

Study Locations (1)

New York

  • Weill Cornell Medicine - New York

Trial Details

FieldValue
Enrollment Target 29 participants
Start Date 2022-05-06
Est. Completion 2023-08-18
Phase NA

What the Registry Record Tells You About NCT05291533

The ClinicalTrials.gov registry entry for NCT05291533 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 29 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (93% lower). The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Anxiety appearing as the primary indexed condition, and to 1 intervention - of which Virtual Reality (VR) Mindfulness Program is the first listed.

NCT05291533 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT05291533 about?

NCT05291533 is a clinical study titled "Patient Experiences With Virtual Reality Mindfulness Skills Training". This study aims to assess acceptability and preliminary efficacy of an intervention being administered clinically, a virtual reality (VR) mindfulness program. It is hypothesized that patients will find VR mindfulness an acceptable intervention and that it will reduce symptoms of anxiety.

What is the current status of trial NCT05291533?

This trial is currently completed. It is a NA study. The enrollment target is 29 participants. The study started on 2022-05-06. Estimated completion is 2023-08-18.

What conditions does trial NCT05291533 study?

This clinical trial studies the following conditions: Anxiety, Distress, Emotional.

What interventions are being tested in trial NCT05291533?

The interventions under investigation include: Virtual Reality (VR) Mindfulness Program (OTHER).

Who is sponsoring clinical trial NCT05291533?

This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05291533 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Anxiety

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.